2 Average System Price is calculated as the sum of revenue related to EyeQ® and SuperVision systems, divided by the number of systems shipped.
Updated Financial Guidance for the 2023 Fiscal Year
We are updating our guidance for the 2023 fiscal year that we last provided on July 27, 2023:
|
|
Updated Guidance
|
|
Previous Guidance
|
||||||||
U.S. dollars in millions |
|
Low |
|
High |
|
Range |
||||||
Revenue |
|
$ |
2,065 |
|
|
$ |
2,090 |
|
|
$ |
2,065 - 2,114 |
|
Operating Loss |
|
$ |
(79 |
) |
|
$ |
(62 |
) |
|
$ |
(129) - (98 |
) |
Amortization of acquired intangible assets |
|
$ |
474 |
|
|
$ |
474 |
|
|
$ |
474 |
|
Share-based compensation expense |
|
$ |
253 |
|
|
$ |
253 |
|
|
$ |
255 |
|
Adjusted Operating Income |
|
$ |
648 |
|
|
$ |
665 |
|
|
$ |
600 - 631 |
|
Our updated guidance reflects a 0.6% reduction in expected Revenue, at the midpoint, as we now expect SuperVision shipments in Q4 of 2023 to be at the lower end of what was incorporated into our previous guidance. Our updated guidance also reflects an improvement in expected Operating Loss (GAAP) and Adjusted Operating Income (Non-GAAP), at the midpoint, of 37% and 7%, respectively, due to lower than expected operating expenses, both in Q3 and Q4 of 2023.